Skip to main content
. 2022 Feb 23;12(3):349. doi: 10.3390/biom12030349

Figure 2.

Figure 2

Changes in left ventricular ejection fraction (LVEF) after 6 and 12 months in Chagas disease patients participating in STCC, after Se (solid lines) or Placebo (traced lines). The effect of Se was statistically significant only in panel (c), in patients starting the trial with a moderate heart disfunction and LVEF lower than 45%. Patients with normal heart function (LVEF ≥ 55%, panel (a) or with mild heart disfunction (LVEF between 45 and 55%, panel (b) did not show a significant effect after Se treatment.